Nuo Therapeutics

Nuo Therapeutics

Nuo Therapeutics

Cytomedix develops biological therapies to address the areas of wound care,inflammation and angiogenesis.
Founded
2001
Raised
$7.5M
Follow us
Alexa global traffic share
Latest funding
$7,500,000
Post-IPO equity - 2016
Team Size
10+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Nuo Therapeutics makes some noise.